Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

Drugs in Context

article

Tim Hardman ; Jean-François Rossi ; Sergey V Efimov ; Natallia V Matsiyeuskaya ; Olga V Boytsova ; Lyudmila Yu Akhieva ; Elena I Kvasova ; Francisco Harrison ; Yulia S Karpova ; Anton Tikhonov ; Nadezhda F Khomyakova

关键词: azoximer bromide (Polyoxidonium®);    COVID-19;    inflammation;    interventional study;   

DOI  :  10.7573/dic.2021-5-2

学科分类：社会科学、人文和艺术（综合）

来源: C S F Medical Communications Ltd.

【 摘 要 】

The authors wish to make the following corrections to theirarticle: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum:The effect of azoximer bromide (Polyoxidonium®) in patientshospitalized with coronavirus disease (COVID-19): an open-label,multicentre, interventional clinical study. Drugs in Context 2021;10: 2021-11-1. DOI: 10.7573/dic.2020-11-1.

【 授权许可】

CC BY-NC-ND